Mega Contracts Monitor ($100M+) — June 17, 2026

85% of the contract value ($264.2M) is already outlaid, reducing future payment risk and providing strong revenue visibility through August 2029.

Cost-plus-fixed-fee structure limits margin upside but reduces execution risk, reinforcing Leidos' position in federal life sciences R&D support.

The $309.6M NSMV V contract is firm-fixed-price with a 7.4-year performance period; any cost overruns will be borne by TOTE, potentially compressing margins.

The $103.3 million firm-fixed-price contract for a complex construction project transfers full cost overrun risk to Kiewit; margins may be compressed.

The $126.4M award runs through August 2024 with no listed options; $52.2M remains obligated, but revenue beyond that depends on a new award or extension.

The Maritime Administration may issue additional NSMV vessel contracts; TOTE's successful delivery on this award would position it for future awards.

Full obligation of $103.3M at award signals stable NPS infrastructure funding; Kiewit could win follow-on park projects.

Two-thirds of total contract value ($229.7M) is civilian, spanning shipbuilding (Maritime Admin), life sciences R&D (NIH), and park infrastructure (NPS). This indicates steady non-defense federal spending in key areas.

{"entity"=>"TOTE SERVICES, LLC", "reason"=>"Carries high fixed-price execution risk on $309.6M vessel build; 85% funding already provided increases margin sensitivity to cost overruns.", "trigger"=>"quarterly earnings disclosures, contract modifications, delivery milestones"}

{"entity"=>"Leidos Holdings, Inc.", "reason"=>"NIH contract expires August 2024; $52.2M remaining obligation limits visibility beyond near term.", "trigger"=>"re-compete announcement for GOCO facility management at Frederick"}

{"entity"=>"Kiewit Infrastructure West Co.", "reason"=>"Complex civil construction with firm-fixed-price risk on $103.3M award; see subcontractor awards.", "trigger"=>"NPS project progress reports, subcontractor announcements"}